Back
Oric Pharmaceuticals, Inc. Stock Predictions
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
48
ORIC
Oric Pharmaceuticals, Inc.
Last Price:
$11.37
Seasonality Move:
1.47%
7 Day Trial
ALL ACCESS PASS
$
7
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiOric Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, Oric Pharmaceuticals, Inc. has on average historically fallen by 0.5% based on the past 5 years of stock performance.
-
Oric Pharmaceuticals, Inc. has fallen lower in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
-
Is Oric Pharmaceuticals, Inc. Stock Undervalued?The current Oric Pharmaceuticals, Inc. [ORIC] share price is $11.39. The Score for ORIC is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
ORIC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Oric Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Oric Pharmaceuticals, Inc. has on average historically fallen by 0.5% based on the past 5 years of stock performance.
Oric Pharmaceuticals, Inc. Stock Rating
Sell
48
Oric Pharmaceuticals, Inc. (ORIC)
is a Sell
Is Oric Pharmaceuticals, Inc. overpriced?
-
Oric Pharmaceuticals, Inc. has fallen lower in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
Oric Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
oricpharma.com
52-Week Data
52-Week High:
14.93
52-Week Low:
3.90
Prediction Charts
Market Cap:
1.1B
Price in USD:
11.39
Volume:
1.3M
Beta:
1.47
Technical Analysis
SMA50:
12.41
SMA100:
11.41
SMA200:
9.37
52-Wk Change:
16.22%
Stock Predictions
-
Is Oric Pharmaceuticals, Inc. stock public?Yes, Oric Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Oric Pharmaceuticals, Inc. stock quote today?The Oric Pharmaceuticals, Inc. stock price is 11.39 USD today.
-
How to buy Oric Pharmaceuticals, Inc. stock online?You can buy Oric Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 12.44 | 12.25 | 13.45 | 12.13 |
| Nov-17 | 12.29 | 12.06 | 12.71 | 11.28 |
| Nov-18 | 11.93 | 11.90 | 12.15 | 11.51 |
| Nov-19 | 11.87 | 11.48 | 12.04 | 11.47 |
| Nov-20 | 12.48 | 11.48 | 12.50 | 11.21 |
| Nov-21 | 11.57 | 11.62 | 11.80 | 11.02 |
| Nov-24 | 11.64 | 11.79 | 12.01 | 11.50 |
| Nov-25 | 11.82 | 11.62 | 12.29 | 11.47 |
| Nov-26 | 11.58 | 11.82 | 11.95 | 11.46 |
| Nov-28 | 11.90 | 11.88 | 12.14 | 11.74 |
| Dec-1 | 11.65 | 11.15 | 11.78 | 11.05 |
| Dec-2 | 11.18 | 10.65 | 11.25 | 10.45 |
| Dec-3 | 10.69 | 10.98 | 11.06 | 10.57 |
| Dec-4 | 10.91 | 11.39 | 11.54 | 10.72 |
Oric Pharmaceuticals, Inc. Earnings
Oric Pharmaceuticals, Inc. Earnings Report: Per Share Oric Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Oric Pharmaceuticals, Inc. Forecast Revenue Growth
Oric Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Oric Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and an increase next year of $0.02 per share.
* Oric Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.